Correction: Abughanam, G., et al. Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren’s Syndrome-Like Disease. Int. J. Mol. Sci. 2019, 20, 4750

Abughanam, Ghada; Elkashty, Osama A.; Liu, Younan; Bakkar, Mohammed O.; Tran, Simon D.

doi:10.3390/ijms22020894

Open AccessCorrection

Correction: Abughanam, G., et al. Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren’s Syndrome-Like Disease. Int. J. Mol. Sci. 2019, 20, 4750

McGill Craniofacial Tissue Engineering and Stem Cells Laboratory, Faculty of Dentistry, McGill University, Montreal, QC H3A 0C7, Canada

^*

Author to whom correspondence should be addressed.

Int. J. Mol. Sci. 2021, 22(2), 894; https://doi.org/10.3390/ijms22020894

Submission received: 3 November 2020 / Accepted: 10 November 2021 / Published: 18 January 2021

(This article belongs to the Special Issue Role and Application of Stem Cells in Regenerative Medicine)

Download Versions Notes

The authors wish to make the following corrections to this paper [1]:

Figure 2B was mistakenly replaced by Figure 2D, the corrected Figure 2 is shown below:

We apologize for any inconvenience brought to the readers.

Reference

Abughanam, G.; Elkashty, O.A.; Liu, Y.; Bakkar, M.O.; Tran, S.D. Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren’s Syndrome-Like Disease. Int. J. Mol. Sci. 2019, 20, 4750. [Google Scholar] [CrossRef] [PubMed] [Green Version]

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

Share and Cite

MDPI and ACS Style

Abughanam, G.; Elkashty, O.A.; Liu, Y.; Bakkar, M.O.; Tran, S.D. Correction: Abughanam, G., et al. Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren’s Syndrome-Like Disease. Int. J. Mol. Sci. 2019, 20, 4750. Int. J. Mol. Sci. 2021, 22, 894. https://doi.org/10.3390/ijms22020894

AMA Style

Abughanam G, Elkashty OA, Liu Y, Bakkar MO, Tran SD. Correction: Abughanam, G., et al. Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren’s Syndrome-Like Disease. Int. J. Mol. Sci. 2019, 20, 4750. International Journal of Molecular Sciences. 2021; 22(2):894. https://doi.org/10.3390/ijms22020894

Chicago/Turabian Style

Abughanam, Ghada, Osama A. Elkashty, Younan Liu, Mohammed O. Bakkar, and Simon D. Tran. 2021. "Correction: Abughanam, G., et al. Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren’s Syndrome-Like Disease. Int. J. Mol. Sci. 2019, 20, 4750" International Journal of Molecular Sciences 22, no. 2: 894. https://doi.org/10.3390/ijms22020894

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Menu

Correction: Abughanam, G., et al. Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren’s Syndrome-Like Disease. Int. J. Mol. Sci. 2019, 20, 4750

Reference

Share and Cite

Article Metrics

Article Access Statistics

Further Information

Guidelines

MDPI Initiatives

Follow MDPI